ACM
SCLN
Ativo Capital Management’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2017
Q2 | – | Sell |
-123,428
| Closed | -$1.21M | – | 246 |
|
2017
Q1 | $1.21M | Hold |
123,428
| – | – | 0.3% | 124 |
|
2016
Q4 | $1.33M | Buy |
123,428
+5,200
| +4% | +$56.2K | 0.31% | 105 |
|
2016
Q3 | $1.21M | Buy |
118,228
+20,222
| +21% | +$207K | 0.28% | 113 |
|
2016
Q2 | $1.28M | Buy |
98,006
+27,768
| +40% | +$363K | 0.31% | 100 |
|
2016
Q1 | $773K | Sell |
70,238
-4,800
| -6% | -$52.8K | 0.21% | 92 |
|
2015
Q4 | $690K | Buy |
75,038
+700
| +0.9% | +$6.44K | 0.17% | 101 |
|
2015
Q3 | $592K | Buy |
74,338
+2
| +0% | +$16 | 0.16% | 126 |
|
2015
Q2 | $657K | Buy |
74,336
+2,773
| +4% | +$24.5K | 0.23% | 82 |
|
2015
Q1 | $634K | Sell |
71,563
-6
| -0% | -$53 | 0.25% | 86 |
|
2014
Q4 | $627K | Hold |
71,569
| – | – | 0.26% | 89 |
|
2014
Q3 | $493K | Buy |
+71,569
| New | +$493K | 0.19% | 97 |
|
2013
Q3 | – | Sell |
-74,545
| Closed | -$370K | – | 207 |
|
2013
Q2 | $370K | Buy |
+74,545
| New | +$370K | 0.19% | 114 |
|